Journal article
Brain‐derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course
Abstract
OBJECTIVES: The neurotrophin brain-derived neurotrophic factor (BDNF) has been proposed as a potential biomarker in bipolar disorder (BD). However, current evidence is limited and results have been highly heterogeneous. This study aimed to assess the moderating effect of impaired glucose metabolism (IGM) on plasma levels of BDNF in individuals with BD, and on the relationship between BDNF and variables of illness course.
METHODS: We measured …
Authors
Mansur RB; Santos CM; Rizzo LB; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni-Graiff M; Cordeiro Q; Vinberg M
Journal
Bipolar Disorders, Vol. 18, No. 4, pp. 373–378
Publisher
Wiley
Publication Date
June 2016
DOI
10.1111/bdi.12399
ISSN
1398-5647